Companies: 10,795·Total market cap: $144.5T

Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc

INDVNASDAQHealthcare● Active

$37.62

+$0.17(+0.44%)

Market Cap$4.7B

P/E Ratio—

52W High$41

52W Low$13.42

Avg Volume2.6M

Open$37.58

Beta1.17

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Indivior Pharmaceuticals Inc（INDV）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · INDV · 截至 Jun 8, 2026

关键指标

EPS (TTM)$2.01Earnings history

PE Ratio (TTM)18.7×PE Ratio deep dive

Revenue (TTM)$1.3BFull revenue history

Dividend Yield4.04%Dividend history

Shares Outstanding125.0MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

探索 Indivior Pharmaceuticals Inc 数据

分析师预测$49 · Buy

营收$1.2B+4.29%

盈利EPS $1.68+11025.83%

市盈率18.7×

财务快照

FY 2025Revenue$1.24B▲ +4.29% YoY

202320242025

FY 2025Net Income$210.0M▲ +10400.00% YoY

202320242025

FY 2025EPS$1.68▲ +11025.83% YoY

202320242025

TTM:Revenue: $1.29BNet Income: $251.0MEPS: $2.01View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$48.00Low

$37.62Current

$49.00Avg Target上涨空间 30.27%

$50.00High

合计: 3 · 买入占比: 100.0%

根据过去 3 个月内 3 位华尔街分析师，INDV 共识评级为 Buy，12 个月平均目标价 $49.00 （较现价 $37.62 上涨空间 30.27%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Indivior Pharmaceuticals Inc

$37.62+0.44%$4.7B #2

ACADIA Pharmaceuticals Inc.

$21.56-0.74%$3.7B #3

ADMA Biologics, Inc.

$7.97-0.13%$1.8B #4

Amneal Pharmaceuticals, Inc.

$13.75+1.70%$4.4B #5

Crinetics Pharmaceuticals, Inc.

$32.92-4.94%$3.5B #6

Hinge Health, Inc.

$63.62+1.02%$4.9B

股票表现

1D+0.44%

1W+11.82%

1M-4.77%

3M+16.56%

YTD+4.84%

1Y+180.08%

5Y+235.85%

关于 Indivior Pharmaceuticals Inc

CEOJoseph J. Ciaffoni

IPO DateDec 29, 2014

Employees1,030

CountryUS

Websiteindivior.com

Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products inc…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQUS

关于股票概览与关键数据

Indivior Pharmaceuticals Inc（INDV）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Dec 29, 2014 在 NASDAQ 上市。截至最近交易日，INDV 股价为 $37.62，市值约为 $4.7B。过去12个月累计回报 +180.08%，年初至今回报 +4.84%。

根据 3 位华尔街分析师，Indivior Pharmaceuticals Inc 股票共识评级为Buy，12个月平均目标价为 $49.00。2025 财年 Indivior Pharmaceuticals Inc 营收 $1.2B，净利润 $210.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Indivior Pharmaceuticals Inc（INDV）股价为 $37.62，在 NASDAQ 上市，52周区间为 $13.42 – $41.00。

INDV 最新股价INDV quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议